• Latest

Eisai Receives Positive Opinion from EMA’s CHMP on Use of Antiepileptic Agent Fycompa in Pediatric Patients

Tokyo, September 23, 2020:  Eisai Co., Ltd. announced that it has received a positive opinion from the European Medicines Agency…